Literature DB >> 8389941

Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells.

V Calvez1, I Pelletier, S Borzakian, F Colbère-Garapin.   

Abstract

Poliovirus mutants were selected during the persistent infection of human neuroblastoma cells. These viruses could establish secondary persistent infections in HEp-2 nonneural cells. We report the identification of a region of the genome of a persistent virus (S11) that was sufficient to confer to a recombinant virus the phenotype that causes persistent infection in HEp-2 cells. This region, between nucleotides 1148 and 3481, contained 11 missense mutations mapping exclusively in the genes of capsid proteins VP1 and VP2. Because recombinant viruses carrying only one of these two mutated genes were not able to cause persistent infection, it seems very probable that two or more mutations in these genes are required for expression of the phenotype that causes persistent infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389941      PMCID: PMC237820     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.

Authors:  K Kirkegaard
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

2.  An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine.

Authors:  M Kohara; S Abe; S Kuge; B L Semler; T Komatsu; M Arita; H Itoh; A Nomoto
Journal:  Virology       Date:  1986-05       Impact factor: 3.616

3.  Prolonged intracerebral infection with poliovirus in asymptomatic mice.

Authors:  J R Miller
Journal:  Ann Neurol       Date:  1981-06       Impact factor: 10.422

4.  Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous system.

Authors:  B Jubelt; S L Ropka; S J Goldfarb; J L Janavs
Journal:  J Neuroimmunol       Date:  1989-05       Impact factor: 3.478

5.  Persistent poliovirus infection of human neuroblastoma cells.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; I Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Persistent infection of human fibroblasts by hepatitis A virus.

Authors:  A Vallbracht; L Hofmann; K G Wurster; B Flehmig
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

7.  Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child.

Authors:  L E Davis; D Bodian; D Price; I J Butler; J H Vickers
Journal:  N Engl J Med       Date:  1977-08-04       Impact factor: 91.245

8.  Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.

Authors:  M G Murray; J Bradley; X F Yang; E Wimmer; E G Moss; V R Racaniello
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

9.  Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.

Authors:  A Martin; C Wychowski; T Couderc; R Crainic; J Hogle; M Girard
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  Observations on encephalomyelitis of mice (DA strain).

Authors:  J B DANIELS; A M PAPPENHEIMER; S RICHARDSON
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

View more
  6 in total

Review 1.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

2.  Persistent poliovirus infection of human fetal brain cells.

Authors:  N Pavio; M H Buc-Caron; F Colbère-Garapin
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice.

Authors:  T Couderc; N Guédo; V Calvez; I Pelletier; J Hogle; F Colbère-Garapin; B Blondel
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Persistent equine arteritis virus infection in HeLa cells.

Authors:  Jianqiang Zhang; Peter J Timoney; N James MacLachlan; William H McCollum; Udeni B R Balasuriya
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.

Authors:  H Zhang; N W Blake; X Ouyang; Y A Pandolfino; P Morgan-Capner; L C Archard
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Antiapoptotic but not antiviral function of human bcl-2 assists establishment of Japanese encephalitis virus persistence in cultured cells.

Authors:  C L Liao; Y L Lin; S C Shen; J Y Shen; H L Su; Y L Huang; S H Ma; Y C Sun; K P Chen; L K Chen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.